WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025, the deal ...

Pharma giant MSD is buying the Dundalk-based vaccines plant of Chinese rival Wuxi in a €500 million deal. Wuxi invested €200 million in 2019 to build the plant, which currently employs 200 ...

The Dundalk site was WuXi's first manufacturing investment in Europe and the company’s first investment of this scale outside of China The MSD site in Dundalk, Co Louth. The Dundalk site will ...

Pharmaceutical firm MSD has agreed a deal to buy the WuXi Vaccines manufacturing facility in Dundalk, Co Louth as part of its long-term plans in Ireland. MSD said the deal is worth €500m and ...

The pharmaceutical firm MSD is buying out the WuXi Vaccines manufacturing plant in Dundalk, in a €500m deal. The American company says that in addition to the 150 jobs at the Dundalk facility ...

Healthcare company MSD Ireland has acquired the state-of -the art WuXoi manufacturing plant in Dundalk, with the official handover expecting to take place during the first half of 2025. It was ...

MSD has expanded its presence in Ireland with an agreement to buy a vaccine manufacturing facility from Chinese biotech WuXi Biologics for around €500 million (around $520 million). The plant in ...

Pharmaceutical giant Merck, which operates as MSD outside of the U.S., is to acquire the WuXi Vaccines manufacturing plant in Dundalk as part of a €500M deal, bringing the U.S.-based company ...

Wuxi Biologics (Cayman) ( (HK:2269) ) has provided an announcement.